| human | Q5 |
| P496 | ORCID iD | 0000-0001-6055-5110 |
| P3829 | Publons author ID | 2733427 |
| P1053 | ResearcherID | E-1200-2012 |
| P1889 | different from | Durval Sarmento da Rosa Borges | Q51882073 |
| P735 | given name | Durval | Q21285819 |
| Durval | Q21285819 | ||
| P106 | occupation | researcher | Q1650915 |
| Q81573672 | Anicteric cholangiopathy in schistosomiasis patients |
| Q43838210 | Early liver dysfunction in schistosomiasis. |
| Q81890258 | Endothelial markers in schistosomiasis patients with or without portal hypertension |
| Q44221073 | Enzyme release from injured, preserved, and ex vivo reperfused liver does not indicate malfunction. |
| Q45209610 | Hemodynamic and metabolic effects of angiotensin II on the liver |
| Q44778304 | Hepatic clearance of tissue-type plasminogen activator and plasma kallikrein in experimental liver fibrosis. |
| Q67247504 | Hypoprothrombinemia in the compensated form of hepatosplenic schistosomiasis: further studies |
| Q36206796 | Kallikrein-kinin system in hepatic experimental models. |
| Q64926632 | Kinin-converting aminopeptidase from human serum. |
| Q73081005 | Participation of a galectin-dependent mechanism in the hepatic clearance of tissue-type plasminogen activator and plasma kallikrein |
| Q72327778 | Plasma kallikrein clearance by the liver of chronic carbon tetrachloride-treated rats |
| Q51602434 | Plasma-kallikrein clearance by the liver of acetaminophen-intoxicated rats. |
| Q37590180 | Portal hypertensive response to kinin. |
| Q78508417 | Serum hyaluronic acid as a comprehensive marker to assess severity of liver disease in schistosomiasis |
| Q73298618 | Thrombocytemia as a predictor of portal hypertension in schistosomiasis |
| Q51882073 | Durval Sarmento da Rosa Borges | different from | P1889 |
Search more.